Patent · US Active

Enalapril compositions

US9968553B1 · kind B1 · utility

8Cited by

25References

30Claims

0Family size

Assignees

SILVERGATE PHARMACEUTICALS, INC. · US
University of Kansas · US

Inventors

Lian G. Rajewski · Lawrence, US
Roger A. Rajewski · Lawrence, US
John L. Haslam · Lawrence, US
Kathleen Heppert · Lawrence, US
Michael C. Beckloff · Leawood, US
Frank Segrave · Dublin, US
Robert Mauro · Miller Place, US
Peter Colabuono · Las Vegas, US

Key dates

Filing date	Dec 21, 2017
Grant date	May 15, 2018
Priority date	—
Expiry date	Dec 21, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.